ASSESSMENT OF THE CLOPIDOGREL ACTION WITH REGARD TO CYP2C19 GENE POLYMORPHISMS IN PATIENTS WITH CORONARY ARTERY DISEASE AFTER IMPLANTATION OF DES STENTS
Jamol UzokovRepublican specialized scientific practical medical center of therapy medical rehabilitationB. A. AlyaviRepublican specialized scientific practical medical center of therapy medical rehabilitationA. Kh. AbdullaevRepublican specialized scientific practical medical center of therapy medical rehabilitation
2019en
ABI
Аннотация
Aim of the work to assess the impact of CYP2C19 polymorphisms, including those of CYP2C19*1, CYP2C19*2, CYP2C19*3 and CYP2C19*17 on clopidogrel response variability in patients undergoing percutaneous coronary intervention (PCI) following DES implantation.
Ҳали таржима қилинмаган
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба